Inhibition of glycogen synthase kinase 3 beta ameliorates liver ischemia reperfusion injury by way of an interleukin-10-mediated immune regulatory mechanism.
about
Mitochondrial Dysfunction and Autophagy in Hepatic Ischemia/Reperfusion InjuryThe TSC complex is required for the benefits of dietary protein restriction on stress resistance in vivoInhibition of glycogen synthase kinase 3β ameliorates D-GalN/LPS-induced liver injury by reducing endoplasmic reticulum stress-triggered apoptosisMyeloid PTEN deficiency protects livers from ischemia reperfusion injury by facilitating M2 macrophage differentiation.Dynamic modulation of innate immune response by varying dosages of lipopolysaccharide (LPS) in human monocytic cells.GSK-3β inhibition attenuates CLP-induced liver injury by reducing inflammation and hepatic cell apoptosis.Lipopolysaccharide preconditioning protects hepatocytes from ischemia/reperfusion injury (IRI) through inhibiting ATF4-CHOP pathway in miceInnate immune programing by endotoxin and its pathological consequencesSilencing of long noncoding RNA AK139328 attenuates ischemia/reperfusion injury in mouse liversIL-11 Attenuates Liver Ischemia/Reperfusion Injury (IRI) through STAT3 Signaling Pathway in Mice.Peroxisome proliferator-activated receptor α activation attenuates the inflammatory response to protect the liver from acute failure by promoting the autophagy pathway.Cromoglycate, not ketotifen, ameliorated the injured effect of warm ischemia/reperfusion in rat liver: role of mast cell degranulation, oxidative stress, proinflammatory cytokine, and inducible nitric oxide synthaseGlycogen synthase kinase 3 inhibitor protects against microvascular hyperpermeability following hemorrhagic shock.Inhibition of GSK3 abolishes bacterial-induced periodontal bone loss in mice.β-Arrestin 2 Promotes Hepatocyte Apoptosis by Inhibiting Akt ProteinWnt agonist attenuates liver injury and improves survival after hepatic ischemia/reperfusion.Carbon monoxide protects against hepatic ischemia/reperfusion injury via ROS-dependent Akt signaling and inhibition of glycogen synthase kinase 3β.Tissue microenvironments define and get reinforced by macrophage phenotypes in homeostasis or during inflammation, repair and fibrosis.Ischaemia-reperfusion injury in liver transplantation--from bench to bedsideTissues use resident dendritic cells and macrophages to maintain homeostasis and to regain homeostasis upon tissue injury: the immunoregulatory role of changing tissue environments.Regulation by glycogen synthase kinase-3 of inflammation and T cells in CNS diseasesSCFFBXO17 E3 ligase modulates inflammation by regulating proteasomal degradation of glycogen synthase kinase-3β in lung epithelia.Methane alleviates carbon tetrachloride induced liver injury in mice: anti-inflammatory action demonstrated by increased PI3K/Akt/GSK-3β-mediated IL-10 expression.Preconditioning methods in the management of hepatic ischemia reperfusion- induced injury: Update on molecular and future perspectives.Ursodeoxycholyl lysophosphatidylethanolamide inhibits cholestasis- and hypoxia-induced apoptosis by upregulating antiapoptosis proteins.Innate Immune Regulations and Liver Ischemia-Reperfusion Injury.Pharmacological inhibition of Akt and downstream pathways modulates the expression of COX-2 and mPGES-1 in activated microgliaChronic lithium treatment protects against liver ischemia/reperfusion injury in rats.Characterization of M1 and M2 polarization of macrophages in vascularized human dermo-epidermal skin substitutes in vivo.Glycogen synthase kinase 3β inhibition promotes human iTreg differentiation and suppressive function.Endoplasmic reticulum stress of Kupffer cells involved in the conversion of natural regulatory T cells to Th17 cells in liver ischemia-reperfusion injury.Glycogen synthase kinase 3 regulates IL-1β mediated iNOS expression in hepatocytes by down-regulating c-Jun.
P2860
Q26771761-1C82F2DA-50D8-4D62-91AB-4AF52379957EQ28246133-CB54E2F0-3EFC-4419-9945-ED42F58B6965Q28484135-F8D83861-98BA-4FE7-8D6A-46832D8D9E03Q33661598-25AEC3EF-E064-4B33-9509-2B493DA5BC10Q33985344-E432A716-A381-4A43-A789-92F898D1BA72Q34697844-AB0BDA5F-E617-411D-A885-E0DAF9D51258Q34764338-F961F915-9E58-441E-A664-EC04178B6F11Q34841012-624E4D72-4758-4351-802A-563F855D642FQ35060368-C50AFE27-A044-46CC-9581-EAA87C2976CBQ35577573-87F3184A-6EF8-41B4-A1EC-2750D7444D5EQ35679584-2CAA9F9F-7465-47BA-AD68-3B0E5E738DFDQ36079408-CFAD7BE8-CB0C-4423-8135-F135FE40F8ECQ36091471-AC93B519-7166-4E1F-8D65-F58A76E39838Q36434353-0B17E596-FA90-4109-BB2A-0D38B2A2C742Q36442343-4371E95C-860B-4CBE-A876-8CAB4A3903EDQ36478869-F1B9A19F-EB81-4D1F-ACB5-FFB3D184847DQ37433294-E49F0C6B-E8A3-4775-8421-C93615582E9AQ38003021-96742EDB-A679-457F-BD7E-00138D3223A3Q38066361-86A39D2D-602C-4C3D-A056-D88B405AA9CBQ38068399-7BEBE1D5-5CF5-48F6-BEF2-97CD11C2C649Q38371329-A31C2CFE-6152-4AC5-A61E-3B1B7C60A9EBQ38712145-5892A05F-0657-42B8-A8A0-30E1E2424B58Q38734973-BA8FB1E8-9979-4C23-BCA1-05F0D530EA4EQ38779827-5E170F97-4F21-4F9E-ABB8-76612643AA01Q38965833-2DE8C5CF-804F-4D0C-A8D5-01C49226E5CAQ39012727-2CBDE3D6-CFF2-4AAF-8237-1FD26100A1E3Q41362782-BACB187B-1EE7-45AF-A334-D2BD24C58AA1Q46917285-3996A7D4-7B9D-4DCC-B3DA-19A19DD7005AQ47362980-5D03ED8B-B768-4E92-9252-2F505BE44198Q51000716-C5C6CED3-B372-4D6F-90FE-499F974CEE46Q53336916-1129B206-7C3F-47DE-8DAD-E13AA021DB76Q55071586-12233F29-FE5D-4CAF-AB31-9BBD45314A26
P2860
Inhibition of glycogen synthase kinase 3 beta ameliorates liver ischemia reperfusion injury by way of an interleukin-10-mediated immune regulatory mechanism.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Inhibition of glycogen synthas ...... d immune regulatory mechanism.
@ast
Inhibition of glycogen synthas ...... d immune regulatory mechanism.
@en
type
label
Inhibition of glycogen synthas ...... d immune regulatory mechanism.
@ast
Inhibition of glycogen synthas ...... d immune regulatory mechanism.
@en
prefLabel
Inhibition of glycogen synthas ...... d immune regulatory mechanism.
@ast
Inhibition of glycogen synthas ...... d immune regulatory mechanism.
@en
P2093
P2860
P50
P356
P1433
P1476
Inhibition of glycogen synthas ...... d immune regulatory mechanism.
@en
P2093
Qiao Cheng
Xiuda Shen
Zhongping Duan
P2860
P304
P356
10.1002/HEP.24419
P407
P577
2011-06-26T00:00:00Z